🚨Friday, 6 May, 09:42 - 10:00🚨 We are excited to be presenting the @collavidence journey and future directions in medical research funding live to the stroke community next week in Lyon #ESOC2022 European Stroke Org Don’t miss it and check out our e-posters as well! #CommitToCure

The pragmatic ACT trial shows that TNK is not inferior to rtPA at achieving mRS 0-1 functional outcomes without any significant safety concerns. #ESOC2022 #stroke

🇨🇦 Calgary 🛫 Paris 🛬 Lyon 🇫🇷 Join Collavidence at #ESOC2022 Check out our e-posters (titles below) and don’t miss the presentation on Friday May 6, 9:42 AM, Scientific Session 27 #stroketwitter #neurotwitter

Alteplase Compared to Tenecteplase in patients with Acute Ischemic Stroke (AcT) Trial: Protocol for a Pragmatic Registry linked Randomized Clinical Trial | Stroke: Vascular and Interventional Neurology ahajournals.org/doi/10.1161/SV… Stroke: Vascular and Interventional Neurology Stroke AHA/ASA SVIN

Several interesting projects have been uploaded to Collavidence. Have a look…🧠🔬 #stroketwitter #neurotwitter 👉 collavidence.com/project/seed-1… 👉 collavidence.com/project/modifi…

Take a look at this promising initiative! Help move stroke research forward together! #CommitToCure #stroke #recovery

#MeVO is the next frontier in EVT!🚀But what are the desired qualities of EVT tools and barriers in #MeVO treatment?🤔We have asked!💡And here is what neurointerventionalists think about it!🌍 link.springer.com/article/10.100… Nima Kashani, MD FRCPC DABR Mayank Goyal Johanna Ospel, MD PhD Manon Kappelhof Jens Fiehler

Collavidence is at #SNIS2022 ✈️ Are you signed up yet? 🌎🌐 👉 collavidence.com #bettermedicinetogether #CommitToCure

Register now for the 5T Stroke Conference in the beautiful Banff Fairmont Springs 🇨🇦 (October 6 to 8, 2022) 🍁 Join us for the latest discussions on Acute Stroke treatment and care. Registration ✍️ & Agenda 🔖 at 5tstroke.ca

Dr. Rosalie McDonough Rosalie McDonough presenting collavidence to the acute stroke/ interventional community at the 5T Stroke Conference Conference at beautiful Banff Fairmont Banff Springs 🇨🇦 Check out our website collavidence.com #bettermedicinetogether

#MedTwitter - we‘d like to introduce the newest feature to the collavidence website! A space for our growing community to boost discussion and collaboration! Check out „Working groups“ on collavidence.com/working-groups #bettermedicinetogether #workinggroups

Proud CO-PI of this amazing project alongside my friend & CO-PI Dr Xunming Ji and all other BAOCHE investigators, Dr Chuanhui Li included. For the first time in BAO (and second time overall),the efficacy of EVT in the 6-24 hr window could be demonstrated. nejm.org/doi/full/10.10…

.Mayank Goyal and Rosalie McDonough recently spoke to NeuroNews to discuss the "culture shift" they want to instigate through @collavidence - an "unconventional" start-up attempting to break down numerous longstanding barriers in #Stroke research neuronewsinternational.com/collavidence-g…

2/ Check out the article in #Stroke 👇 ahajournals.org/doi/10.1161/ST… Michael D Hill Martha Marko @nimakashani Johanna Ospel, MD PhD Petra Cimflova nishita singh #AHAJournals

In our recent study: Interaction between tortuosity, thrombus characteristics, and first-line EVT strategy: *Probability of FPE with contact aspiration⏬with higher tortuosity. *Longer thrombi were associated with⏫number of passes in the aspiration group journals.sagepub.com/eprint/NB7INWZ…

New online JNIS: ⬇️mRS 0-2 in incomplete reperfusion than near complete reperfusion ⬇️ mRS 0–2 MT-accessible occlusion than non-MT-accessible occlusion pattern. ⬆️ patients with MT-accessible occlusion had infarcts than with non-MT occlusion pattern (68% vs46%).

Perforator aneurysms are rare and intriguing subtypes of intracranial aneurysms. Have you seen aneurysms of lenticulostriate, thalamo or basilar perforating arteries? join us: [email protected] ESMINT Society SNIS Info SVIN Johannes Kaesmacher David Bervini Johannes Goldberg Eike Piechowiak

Ever wondered how to do the stats for your first paper?🤔Don't you worry - We at EYMINT got your back! The one and only Michael D Hill talking about #statistics in #neurointervention for #earlycareer researchers! Part 1⃣ of a multi-part webinar series ➡️esmint.eu/news/webinar-e…